Peer Review History
| Original SubmissionOctober 22, 2020 |
|---|
|
PONE-D-20-33251 A pseudomolecule assembly of the Rocky Mountain elk genome reveals putative immune system gene loss near chromosomal fissions PLOS ONE Dear Dr. Masonbrink, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The expert reviewers have provided valuable feedback that will improve the manuscript . Please address each and every point. Please submit your revised manuscript by Feb 20 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, F. Alex Feltus, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. As part of your revision, please complete and submit a copy of the Full ARRIVE 2.0 Guidelines checklist, a document that aims to improve experimental reporting and reproducibility of animal studies for purposes of post-publication data analysis and reproducibility: https://arriveguidelines.org/sites/arrive/files/Author%20Checklist%20-%20Full.pdf (PDF). Please include your completed checklist as a Supporting Information file. Note that if your paper is accepted for publication, this checklist will be published as part of your article. 3. Please amend the manuscript submission data (via Edit Submission) to include author Jenny Wilson-Welder. 4. Please include a copy of Tables 1, 2, 3 and 4 which you refer to in your text on page 9 and 10. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: ## General comments ## The authors have provided a genome assembly for Rocky Mountain elk (Cervus canadensis), which is a resevoir for Brucella abortus (a bacterium causing abortion). The genome assembly seems to be well put together and so is the annotation (see below for a couple of questions). They compare the immune gene complement of cattle to the elk genome, and find that elk is likely missing several immune genes. The authors basically indicate that these missing genes might be the cause of the poor respons to vaccination in elk. It would have been good to see more discussion around this topic when you do raise it. Do you actually pin-point the genetic basis for this inherent difference, or did you just find some missing genes that happened to be immune genes (and no relation to vaccination)? ## Specific comments ## Line 57: Comma should be after the reference. Genome assembly: It is common to polish with PacBio reads using arrow (https://github.com/PacificBiosciences/GenomicConsensus). Why did you not do this? If you had done this on the scaffolds/pseudochromosomes, you might have closed some smaller gaps even. Line 115: How much coverage did you have with CCS reads? It is not clear to me (maybe I missed it) exactly what kind of PacBio library you created. I assume you tried to get the longest reads possible (please add information about this to the manuscript), and then you’d likely not have much coverage in CCS reads. Line 125: Or do you mean “the mitochondrion»? Line 129: How do you correct the scaffold with samtools? Just samtools faidx and coordinates? Line 148: Do you mean that you ran this through Mikado once more? Interesting approach that results in quite conservative gene annotation I would assume. Line 182-3: You didn’t map the CLRs to the genome? They would likely map at a lower rate, but could be interesting to see. Line 233: Loss of genes is always a bit iffy to discuss. For instance, while you did not find these genes in the genome, were they also lacking from the reads? (Or from the transcriptome reads.) Or, did you look at the (micro)synteny in the affected regions and saw that where you expected the genes to be, there were none and no gaps or otherwise suspiscious sequence? I would like either of these investigations to be done. So, either confirm that the genes are also lacking from the raw reads, or confirm that they are not found based on synteny. Line 246: How would the lack of these genes be utilized in developing a vaccine? I don’t know myself, but when you state this, I would like a bit more elaboration. One approach would be to get transcription data from infected/non-infected individuals to see what the immune system actually does. Line 258: The github site for all programs and scripts were not available when I tried accessing it (27th November). It is great that you provide the scripts and such in that way, but unfortunate that I could not go in and browse the repository. The SRA project is also not available (PRJNA657053). Reviewer #2: The Masonbrink et al. work describes a chromosome-level genome assembly for the Rocky Mountain elk. This new resource will be extremely valuable for the understanding of the elk's immune system and consequently to the prevention of the spread of brucellosis from elk to cattle. The manuscript is well written and is easy to follow and the putative loss of immune-related genes in the elk show promise for better understand the differences between elk and cattle immune system. I do have a few comments that I hope will help further improve it. My main comment relates to the identification of putative gene losses. The result is very interesting and promising. Nonetheless, I believe this section needs a couple of extra checks to support these findings, as these are highlighted in the title and will set this work apart from a regular genome assembly report. For example, could any DNA or RNA seq reads be mapped to the cattle gene sequence? Since many of the putative missing genes are at the end of cattle chromosomes they could be within repetitive regions that are more difficult to assemble, but these sequences could still be recovered in the raw data. Other tool the authors could consider using is TOGA (https://github.com/hillerlab/TOGA) which uses pairwise genome alignments to infer orthologous genes between related species and to accurately distinguish orthologs from paralogs or processed pseudogenes. This could be useful to identify genes that were completely lost from pseudogenes, and also identify the mutations which could have led to pseudogenization. Other comments: 1) Page 6 line 132: the parameters used for repeat annotation are not indicated. 2) Page 6 line 135: RNA-seq library prep and tissues/cells used are not mentioned in the methods section. The tissues used are listed in the results (page 10 line 201), but I believe they should also be indicated in this section. 3) Page 8 line 175: is the number of assembled molecules the expected number of chromosomes of the elk? Maybe a citation to a cytogenetics work with that information could be added (e.g. Koulischer, L., et al. (1972). Mammalian cytogenetics. VII. The chromosomes of Cervus canadensis, Elaphurus davidianus, Cervus nippon (Temminck) and Pudu pudu. Acta Zoologica et Pathologica Antverpiensia, 56, 25-30). 4) Page 8 line 185: is there a reason behind not using the mammalian busco set? If used it might give the opportunity to compare the completeness of the assembled genome to that of C. elaphus. 5) The reviewer pack did not contain supplemental tables so I could not review those. 6) There are a few typos or multiple versions of the same word across the manuscript that should be fixed for consistency (e.g. Hi-C vs HI-C vs HiC; elk vs Elk; missing spaces after references; extra commas). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Ole K. Tørresen Reviewer #2: Yes: Joana Damas [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-33251R1 A pseudomolecule assembly of the Rocky Mountain elk genome PLOS ONE Dear Dr. Masonbrink, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address Reviewer' #2's remaining comment. Almost there! Please submit your revised manuscript by Apr 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, F. Alex Feltus, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: My concerns have mostly been addressed. I believe section describing the putative gene loss could still be further improved. For example, how does the elk genome sequence look on the regions these genes were expected to locate? Are there gaps? Are these contiguous regions? It would also be very interesting to see if there are still remnants of these genes in the elk genome? Or are these genes located at the boundaries of chromosomal inversions, for example? Nonetheless, I do understand that the last two questions might require more time to investigate. The information about the sequence contiguity around these putative lost genes, however, would address the concerns of misassembly in these regions. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Joana Damas [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
A pseudomolecule assembly of the Rocky Mountain elk genome PONE-D-20-33251R2 Dear Dr. Masonbrink, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, F. Alex Feltus, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-33251R2 A pseudomolecule assembly of the Rocky Mountain elk genome Dear Dr. Masonbrink: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. F. Alex Feltus Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .